Related Experiment Video
Updated: Jul 21, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
Published on: February 20, 2019
The role of stem cells in atherosclerosis
Q Xu1
1Department of Cardiac and Vascular Sciences, St George's Hospital Medical School, London, UK. q.xu@sghms.ac.uk
Insights
Stem and progenitor cells drive arteriosclerosis development and lesion formation. These cells contribute to endothelial repair and smooth muscle cell accumulation, offering potential for vascular disease therapies.
Area of Science:
- Vascular Biology
- Stem Cell Research
- Atherosclerosis Pathogenesis
Background:
- Arteriosclerosis involves stem and progenitor cells in various forms, including transplant arteriosclerosis, restenosis, and spontaneous atherosclerosis.
- Stem/progenitor cells in circulation and adventitia are implicated in endothelial repair and smooth muscle cell accumulation.
Purpose of the Study:
- To elucidate the role of stem/progenitor cells in the initiation and progression of arteriosclerosis.
- To investigate the contribution of these cells to atherosclerotic lesion formation and vascular repair.
Main Methods:
- Review of accumulating evidence on stem/progenitor cell involvement in vascular disease.
- Analysis of mechanisms including endothelial death, cell replacement, migration, proliferation, and differentiation.
Main Results:
- Atherosclerosis initiation involves endothelial death and replacement by stem/progenitor cells.
- Progenitor cells migrate to the intima, proliferate, and differentiate into new smooth muscle cells (neo-SMC).
- Stem/progenitor cells are central to the inflammatory process of atherosclerotic lesion formation.
Conclusions:
- Stem/progenitor cells serve as a source for endothelial cells and smooth muscle cells in arteriosclerosis.
- These findings have significant implications for cellular, genetic, and tissue engineering strategies for vascular disease treatment.
Abstract:
Accumulating evidence indicates the involvement of stem cells and/or progenitors in the development of arteriosclerosis, including transplant arteriosclerosis, angioplasty-induced restenosis, vein graft atherosclerosis and spontaneous atherosclerosis. Recently, it was demonstrated that stem/progenitor cells existing in the circulation and adventitia contribute to endothelial repair and smooth muscle cell (SMC) accumulation. Atherosclerosis can be initiated by endothelial death in specific areas, e.g. bifurcation regions, and subsequent replacement by stem/progenitor cells. Meanwhile, progenitor cells from blood and the adventitia migrate into the intima where they proliferate and differentiate into neo-SMC. Stem/progenitor cells are responsible for the formation of atherosclerotic lesions, which appear as an inflammatory disease. Thus, these cells may be a source of endothelial cells and SMC, and might have implications for cellular, genetic, and tissue engineering approaches to vascular disease.
Related Concept Videos
Inflammation
Mesenchymal Stem Cells
Stem Cell Niche
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Coronary Artery Disease II: Pathophysiology
Atherosclerosis I: Introduction

